A Nomogram Model Based on Noninvasive Bioindicators to Predict 3-Year Risk of Nonalcoholic Fatty Liver in Nonobese Mainland Chinese: A Prospective Cohort Study

被引:28
作者
Cai, Xintian [1 ]
Aierken, Xiayire [1 ]
Ahmat, Ayguzal [1 ]
Cao, Yuanyuan [1 ]
Zhu, Qing [1 ]
Wu, Ting [1 ]
Li, Nanfang [1 ]
机构
[1] Peoples Hosp Xinjiang Uygur Autonomous Reg, Xinjiang Hypertens Inst, Natl Hlth Comm, Hypertens Ctr,Key Lab Hypertens Clin Res, Urumqi, Peoples R China
关键词
LIPOPROTEIN CHOLESTEROL RATIO; GAMMA-GLUTAMYL-TRANSPEPTIDASE; INSULIN-RESISTANCE; INDEPENDENT PREDICTOR; GLOBAL EPIDEMIOLOGY; YOUNG-ADULTS; DISEASE; POPULATION; DIAGNOSIS; STEATOHEPATITIS;
D O I
10.1155/2020/8852198
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The purpose of this study is to establish and validate an accurate and personalized nonalcoholic fatty liver disease (NAFLD) prediction model based on the nonobese population in China. This study is a secondary analysis of a prospective study. We included 6,155 nonobese adults without NAFLD at baseline, with a median follow-up of 2.3 years. Univariate and multivariate Cox regression analyses were used to determine independent predictors. The least absolute shrinkage and selection operator (LASSO) regression analysis was used to optimize the selection of variables. Based on the results of multivariate analysis, a prediction model was established. Harrell's consistency index (C-index) and area under the curve (AUC) were used to determine the discrimination of the proposed model. The goodness of fit of the calibration model was tested, and the clinical application value of the model was evaluated by decision curve analysis (DCA). The participants were randomly divided into a training cohort (n=4,605) and a validation cohort (n=1,550). Finally, seven of the variables (HDL-c, BMI, GGT, ALT, TB, DBIL, and TG) were included in the prediction model. In the training cohort, the C-index and AUC value of this prediction model were 0.832 (95% confidence interval (CI), 0.820-0.844) and 0.861 (95% CI, 0.849-0.873), respectively. In the validation cohort, the C-index and AUC values of this prediction model were 0.829 (95% CI, 0.806-0.852) and 0.859 (95% CI, 0.841-0.877), respectively. The calibration plots demonstrated good agreement between the estimated probability and the actual observation. DCA demonstrated a clinically effective predictive model. Our nomogram can be used as a simple, reasonable, economical, and widely used tool to predict the 3-year risk of NAFLD in nonobese populations in China, which is helpful for timely intervention and reducing the incidence of NAFLD.
引用
收藏
页数:12
相关论文
共 59 条
[1]   Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes [J].
Ahmed, Aijaz ;
Wong, Robert J. ;
Harrison, Stephen A. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (12) :2062-2070
[2]   Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults [J].
Alexander, Myriam ;
Loomis, A. Katrina ;
van der Lei, Johan ;
Duarte-Salles, Talita ;
Prieto-Alhambra, Daniel ;
Ansell, David ;
Pasqua, Alessandro ;
Lapi, Francesco ;
Rijnbeek, Peter ;
Mosseveld, Mees ;
Avillach, Paul ;
Egger, Peter ;
Dhalwani, Nafeesa N. ;
Kendrick, Stuart ;
Celis-Morales, Carlos ;
Waterworth, Dawn M. ;
Alazawi, William ;
Sattar, Naveed .
BMJ-BRITISH MEDICAL JOURNAL, 2019, 367
[3]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[4]  
[Anonymous], 2017, MEDICINE
[5]   Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future [J].
Araujo, Ana Ruth ;
Rosso, Natalia ;
Bedogni, Giorgio ;
Tiribelli, Claudio ;
Bellentani, Stefano .
LIVER INTERNATIONAL, 2018, 38 :47-51
[6]   Nomograms in oncology: more than meets the eye [J].
Balachandran, Vinod P. ;
Gonen, Mithat ;
Smith, J. Joshua ;
DeMatteo, Ronald P. .
LANCET ONCOLOGY, 2015, 16 (04) :E173-E180
[7]   NAFLD: A multisystem disease [J].
Byrne, Christopher D. ;
Targher, Giovanni .
JOURNAL OF HEPATOLOGY, 2015, 62 :S47-S64
[8]   Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study [J].
Chang, Yoosoo ;
Ryu, Seungho ;
Sung, Ki-Chul ;
Cho, Yong Kyun ;
Sung, Eunju ;
Kim, Han-Na ;
Jung, Hyun-Suk ;
Yun, Kyung Eun ;
Ahn, Jiin ;
Shin, Hocheol ;
Wild, Sarah Helen ;
Byrne, Christopher D. .
GUT, 2019, 68 (09) :1667-1675
[9]   Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease [J].
du Plessis, Johannie ;
van Pelt, Jos ;
Korf, Hannelie ;
Mathieu, Chantal ;
van der Schueren, Bart ;
Lannoo, Matthias ;
Oyen, Tom ;
Topal, Baki ;
Fetter, Gary ;
Nayler, Simon ;
van der Merwe, Tessa ;
Windmolders, Petra ;
Van Gaal, Luc ;
Verrijken, An ;
Hubens, Guy ;
Gericke, Martin ;
Cassiman, David ;
Francque, Sven ;
Nevens, Frederik ;
van der Merwe, Schalk .
GASTROENTEROLOGY, 2015, 149 (03) :635-+
[10]   Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030 [J].
Estes, Chris ;
Anstee, Quentin M. ;
Teresa Arias-Loste, Maria ;
Bantel, Heike ;
Bellentani, Stefano ;
Caballeria, Joan ;
Colombo, Massimo ;
Craxi, Antonio ;
Crespo, Javier ;
Day, Christopher P. ;
Eguchi, Yuichiro ;
Geier, Andreas ;
Kondili, Loreta A. ;
Kroy, Daniela C. ;
Lazarus, Jeffrey V. ;
Loomba, Rohit ;
Manns, Michael P. ;
Marchesini, Giulio ;
Nakajima, Atsushi ;
Negro, Francesco ;
Petta, Salvatore ;
Ratziu, Vlad ;
Romero-Gomez, Manuel ;
Sanyal, Arun ;
Schattenberg, Joern M. ;
Tacke, Frank ;
Tanaka, Junko ;
Trautwein, Christian ;
Wei, Lai ;
Zeuzem, Stefan ;
Razavi, Homie .
JOURNAL OF HEPATOLOGY, 2018, 69 (04) :896-904